HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CIR Reopens Benzoic Acid To Review Inhalation Effects

This article was originally published in The Rose Sheet

Executive Summary

The Cosmetic Ingredient Review Expert Panel is reopening benzoic acid to study its inhalation effects, the panel decided during its April 3-4 meeting in Washington, D.C

You may also be interested in...



CIR Reopens Botanical Safety Assessment, Issues Formal Data Requests

The Cosmetic Ingredient Review Expert Panel is reopening its safety assessment of Calendula officinalis to study whether the botanical extracts are safe for use in leave-on cosmetic products, the panel announced during its Dec. 4-5 meeting in Washington, D.C

CIR Reopens Botanical Safety Assessment, Issues Formal Data Requests

The Cosmetic Ingredient Review Expert Panel is reopening its safety assessment of Calendula officinalis to study whether the botanical extracts are safe for use in leave-on cosmetic products, the panel announced during its Dec. 4-5 meeting in Washington, D.C

Data Submission To CIR Could Be Limited To Accelerate Reviews

The Cosmetic Ingredient Review Expert Panel will consider condensing the timeframe in which industry can submit data to accelerate the panel's review of cosmetic ingredients, CIR Director Alan Andersen, PhD, said during the panel's meeting April 3-4 in Washington, D.C

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013846

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel